461 Mrv1909 05171921392D 16 17 0 0 0 0 999 V2000 8.1296 1.2513 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.9867 0.0143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.7011 0.4266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5579 0.0143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5579 -0.8105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2725 0.4266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.4149 0.0143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.9867 -0.8105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2725 -1.2229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8207 0.4551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8207 -1.2513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.1296 0.4266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.8438 0.0143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0732 0.0314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0732 -0.8277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3197 -1.1631 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 12 1 0 0 0 0 2 3 1 0 0 0 0 2 6 2 0 0 0 0 2 8 1 0 0 0 0 3 7 1 0 0 0 0 4 5 2 0 0 0 0 4 6 1 0 0 0 0 4 10 1 0 0 0 0 5 9 1 0 0 0 0 5 11 1 0 0 0 0 7 12 1 0 0 0 0 8 9 2 0 0 0 0 12 13 1 0 0 0 0 15 14 1 0 0 0 0 10 14 2 0 0 0 0 11 15 2 0 0 0 0 15 16 1 0 0 0 0 M END > DBMET02537 > drugbank > CC(O)CCC1=CC2=C(C=C1)C=C(O)C=C2 > InChI=1S/C14H16O2/c1-10(15)2-3-11-4-5-13-9-14(16)7-6-12(13)8-11/h4-10,15-16H,2-3H2,1H3 > ATMFTHAMCVAMOK-UHFFFAOYSA-N > C14H16O2 > 216.28 > 216.115029755 > 2 > 32 > 24.872110232987865 > 1 > 2 > 0 > 1 > 6-(3-hydroxybutyl)naphthalen-2-ol > 3.32 > 3.0416123783333338 > -3.66 > 0 > 2 > 0 > 15.652934686203588 > 9.78931043553739 > -2.5132066282944034 > 40.46 > 65.07980000000002 > 3 > 1 > 4.76e-02 g/l > (1S,2R,3S,4S)-2,3,4,5-tetrahydroxy-6-({[2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-yl]oxy}methyl)cyclohexane-1-carboxylic acid > 0 > DBMET02537 > 4-(6-hydroxy-2-naphthyl)- butan-2-ol > 49OFA35110 $$$$